NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Antimicrobial Resistance and Modernising Microbiology

You are here: Home > News listings for Antimicrobial Resistance and Modernising Microbiology

News for Antimicrobial Resistance and Modernising Microbiology

Blog: Developing a process to monitor populations at increased risk from coronavirus

11 March 2022 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19

Emma Pritchard is a Medical Statistician in the Modernising Medical Microbiology team at the John Radcliffe Hospital in Oxford. She works in the Oxford BRC’s Antimicrobial Resistance and Modernising Microbiology Theme. In this blog, Emma explains how she used the ongoing Office for National Statistics COVID-19 Infection Survey to understand the spread of coronavirus in … Read more

COVID-19 blog: accelerating testing with robotics

21 February 2022 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19

PhD student Kevin Chau, who works in the Oxford BRC’s Antimicrobial Resistance and Modernising Microbiology Theme, has played his part in the pandemic response as part of the Modernising Medical Microbiology team at the John Radcliffe Hospital in Oxford. In this blog post written for the Medical Research Foundation, he describes the experience: The swift … Read more

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

19 October 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology

Gene sequencing

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments. The Comprehensive Resistance Prediction for Tuberculosis International Consortium (CRyPTIC) research project has collected the largest ever global dataset of clinical M. tuberculosis samples … Read more

New study launched to understand vaccine escape

26 August 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19, Gastroenterology and Mucosal Immunity, Vaccines for Emerging and Endemic Diseases

Oxford researchers will be involved in a major new study seeking to understand why some people become infected after vaccination or prior infection while others do not Oxford BRC-supported investigators already involved in the Protective Immunity from T-Cells in Healthcare workers (PITCH) study will be part of a consortium of academic partners involved in the … Read more

Vaccination still best protection, but less effective against Delta variant, study finds

19 August 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

The latest findings of an ongoing national study of COVID-19 immunity in households across the UK has found that the Pfizer-BioNTech and Oxford-AstraZeneca vaccines offer good protection against new infections of the Delta variant of concern, but that effectiveness is reduced compared with the Alpha variant. The COVID-19 infection survey, led by Oxford University and … Read more

Antiviral drug could be given to more chronic hepatitis B patients, study finds

14 July 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data

A study by Oxford University researchers has found that the antiviral drug TDF may benefit a greater number of patients with chronic hepatitis B virus, and that those who are untreated may be at greater risk of liver inflammation and fibrosis. The research was carried out under the auspices of the National Institute for Health … Read more

New Senior Research Fellows named

1 July 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Cardiovascular, Imaging, Musculoskeletal, Neurological Conditions, Other News

The NIHR Oxford BRC has announced the appointment of its latest group of Senior Research Fellows – the third cohort of emerging research leaders to receive the accolade. Like in 2020, this year’s selection process was a coordinated effort by the Oxford BRC and its partners in the NIHR Oxford Health BRC, which focuses on mental health … Read more

Latest data on immune response to COVID-19 reinforces need for vaccination

17 June 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19, Gastroenterology and Mucosal Immunity, Vaccines for Emerging and Endemic Diseases

A new study led by University of Oxford has found that previous infection, whether it was symptomatic or asymptomatic, does not necessarily protect you long term from COVID-19, particularly against new variants of concern. The PITCH Study (Protective Immunity from T cells to COVID-19 in Health workers) examined how the immune system responds to COVID-19 … Read more

Partnership to speed up identification of COVID-19 variants

18 May 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology

Oxford University and the multinational computer technology corporation Oracle have joined forces to create a Global Pathogen Analysis System (GPAS) to help governments and medical communities identify and act on variants of the COVID-19 virus faster. The emergence of more infectious variants is threatening to slow the global recovery and potentially thwart current vaccine immunity. The … Read more

BRC researcher receives national infection prevention award

17 May 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data

An NIHR Oxford Biomedical Research Centre researcher who has played a leading role in Oxford University Hospitals (OUH) NHS Foundation Trust’s COVID-19 staff testing programme is to receive a national award. Dr David Eyre (pictured) has been named as the recipient of the Healthcare Infection Society’s (HIS) 2021 Early Career Award in recognition of his … Read more

National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines

23 April 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19, Vaccines for Emerging and Endemic Diseases

Data from the national COVID-19 Infection Survey, which is led by senior NIHR Oxford BRC researcher Professor Sarah Walker, has revealed the impact of vaccination on antibody responses and new infections in a large group of adults from the general population. This major community surveillance survey, one of the NIHR’s COVID-19 urgent public health studies, … Read more

Human challenge trial launches to study immune response to COVID-19

19 April 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19, Vaccines for Emerging and Endemic Diseases

Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected. The team, led by the NIHR Oxford Biomedical Research Centre Director Professor Helen McShane (pictured right), also want to find out how the immune system reacts to a second … Read more

New study finds strong immune response following COVID-19 vaccination

26 March 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19, Gastroenterology and Mucosal Immunity, Vaccines for Emerging and Endemic Diseases

A new study has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine, and that after two doses levels of protection were even stronger. The PITCH (Protective Immunity from T cells to COVID-19 in Health workers) study, led by Oxford and Sheffield Universities with … Read more

Two doses of vaccine offer same protection from COVID as prior infection, study finds

15 March 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19, Vaccines for Emerging and Endemic Diseases

Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found. None of the 1,456 healthcare workers at Oxford University Hospitals (OUH) NHS Foundation Trust who had received two vaccines had a symptomatic infection … Read more

Lateral flow devices found to be useful in screening OUH staff for coronavirus

11 February 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

Infection prevention and control clinicians and researchers at Oxford University Hospitals (OUH) have been outlining the OUH’s experience of deploying self-administered home-based lateral flow testing of its staff. In a letter published in the Journal of Infection, they said that 46,503 home-based SARS-CoV-2 lateral flow tests had been performed by asymptomatic OUH hospital staff. Of … Read more

Lateral flow devices detect most infectious COVID-19 cases, study shows

22 January 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

Researchers from the University of Oxford, working with Public Health England, have used NHS Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others, and if lateral flow tests are sufficient in detecting those who are most infectious.  Using information from over a quarter of … Read more

Prior COVID-19 infection offers protection from re-infection for at least six months

20 November 2020 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection. The study, done as part of a major collaboration between the University of Oxford and Oxford University Hospitals (OUH) NHS Foundation Trust, was published today as a … Read more

COVID antibodies wane within months, healthcare workers study shows

5 November 2020 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

Antibodies to COVID-19 fall by half in less than 90 days, and antibody levels peak lower and fall faster in younger adults, an ongoing study of staff at Oxford University Hospitals NHS Foundation Trust has revealed. The findings, published on the pre-print server medRxiv, also showed that antibodies to the virus last longer in people … Read more

Prof Sarah Walker receives OBE

12 October 2020 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19

Professor Sarah Walker, the Oxford BRC’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology, is to receive an OBE. Prof Walker, Professor of Medical Statistics and Epidemiology at the University of Oxford’s Nuffield Department of Medicine, was recognised for services to academia and the COVID-19 response. She is the chief investigator and academic lead for … Read more

Evaluation of LamPORE rapid Covid-19 tests show high levels of diagnostic sensitivity

25 September 2020 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19

Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. This technology, which combines loop-mediated isothermal amplification with nanopore sequencing, has the potential to analyse thousands of samples per day on a single instrument. The full evaluation paper was published … Read more

  • 1
  • 2
  • 3
  • Next Page »

Antimicrobial Resistance and Modernising Microbiology Theme

  • Introduction
  • Infections in Oxfordshire Research Database (IORD)
  • IORD – Ongoing approved projects and project outputs
  • Contacts
  • Videos for this theme
  • News for this theme
  • General News Listings

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre